Results

Total Results: 1,149 records

Showing results for "drugs".

1. Prescribing Patterns of Cost-Effective Drugs (pdf file)
   digital.ahrq.gov/sites/default/files/docs/page/prescribing-patterns-of-cost-effective-drugs-quick-reference-guide.pdf
   April 01, 2009 - Prescribing Patterns of Cost-Effective Drugs Prescribing Patterns of Cost­Effective Drugs Evaluating … You may want to only examine a particular category of drugs. … to adjust for drug categories to account for possible confounding, since different categories of drugs … This includes taking into account classes of drugs where e­prescribing may not be an option, for example … AHRQ Publication No: 09­0047 April 2009 Prescribing Patterns ofCost-Effective Drugs Methodology

2. Use of hepatotoxic drugs in chronic liver disease. | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics-4
   January 01, 2023 - Use of hepatotoxic drugs in chronic liver disease. … Use of hepatotoxic drugs in chronic liver disease. J Patient Saf 2012 Jun;8(2):45-50.

3. Querying the National Drug File Reference Terminology (NDFRT) to assign drugs to decision support categories. | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/value-new-drug-labeling-knowledge-e-prescribing/citation/querying-national-drug
   January 01, 2023 - Querying the National Drug File Reference Terminology (NDFRT) to assign drugs to decision support categories … Querying the National Drug File Reference Terminology (NDFRT) to assign drugs to decision support categories

4. Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs. | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/impact-office-based-e-prescribing-prescribing-processes-and-outcomes/citation-1
   January 01, 2023 - Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid … Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid

5. Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools. | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/health-information-technology-and-improving-medication-use/citation-2
   January 01, 2023 - Preventability of adverse drug events involving multiple drugs using publicly available clinical decision … Preventability of adverse drug events involving multiple drugs using publicly available clinical decision

6. A shared decision-making tool for drug interactions between warfarin and nonsteroidal anti-inflammatory drugs: Design and usability study. | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/enabling-shared-decision-making-reduce-harm-drug-interactions-end-end/citation/shared
   January 01, 2023 - shared decision-making tool for drug interactions between warfarin and nonsteroidal anti-inflammatory drugs … shared decision-making tool for drug interactions between warfarin and nonsteroidal anti-inflammatory drugs

7. Drugs that interact with colchicine via inhibition of cytochrome p450 3A4 and p-glycoprotein: A signal detection analysis using a database of spontaneously reported adverse events (FAERS). | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/drugs
   January 01, 2023 - Drugs that interact with colchicine via inhibition of cytochrome p450 3A4 and p-glycoprotein: A signal … Drugs that interact with colchicine via inhibition of cytochrome p450 3A4 and p-glycoprotein: A signal

8. Risk of bleeding with exposure to warfarin and nonsteroidal anti-inflammatory drugs: a systematic review and meta-analysis. | Digital Healthcare Research
   digital.ahrq.gov/ahrq-funded-projects/individualized-drug-interaction-alerts/citation/risk
   January 01, 2023 - Risk of bleeding with exposure to warfarin and nonsteroidal anti-inflammatory drugs: a systematic review … Risk of bleeding with exposure to warfarin and nonsteroidal anti-inflammatory drugs: a systematic review

9. NDC | Digital Healthcare Research
   digital.ahrq.gov/ndc
   January 01, 2023 - are ambiguous; many NDCs can exist for a single product, leading to inaccuracies in the dispensing of drugs … Library of Medicine (NLM) has been working on RxNorm , which provides "standard names for clinical drugs … Background The National Drug Codes (NDCs) are standards for reporting drugs and biological products … The Drug Listing Act of 1972 requires that all drug-producing establishments report to the FDA all drugs … Only selected non-prescription drugs are included in the NDC database.

10. Tools for Optimizing Medication Safety (TOP-MEDS) - 2011 | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/tools-optimizing-medication-safety-top-meds/annual-summary/2011
    January 01, 2011 - initiative to conduct research and provide education to advance the optimal use of therapeutics such as drugs … High-risk commonly used drugs such as opioid analgesics are frequently selected and dosed improperly. … Drug name confusion causes patients to receive the wrong drugs. … Consumers use drugs unsafely because drug information is limited and/or confusing.

11. Tools for Optimizing Medication Safety (TOP-MEDS) - 2012 | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/tools-optimizing-medication-safety-top-meds/annual-summary/2012
    January 01, 2012 - initiative to conduct research and provide education to advance the optimal use of therapeutics such as drugs … High-risk commonly used drugs such as opioid analgesics are frequently selected and dosed improperly. … Drug name confusion causes patients to receive the wrong drugs. … Consumers use drugs unsafely because drug information is limited and confusing.

12. Assessment of Pediatric Look-Alike, Sound-Alike Substitution Errors - 2012 | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/assessment-pediatric-look-alike-sound-alike-substitution-errors/annual-summary/2012
    January 01, 2012 - The Delphi process identified the drugs that the participants thought to be of high potential patient … team used a Food and Drug Administration (FDA) file that cross-referenced the brand name and generic drugs … drug pairs included in the final round of the Delphi process did not have a person who received both drugs … errors for these pairs is feasible in the pharmacy setting, so any patient who receives both of these drugs … For 505 pairs (83 percent), the cumulative total of subjects who received both drugs in a pair was 3,610

13. Improving Lab Follow-up by Delivering an Enhanced Medication List to Outpatient Physician Practices | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/improving-lab-follow-delivering-enhanced-medication-list-outpatient-physician
    January 01, 2023 - reminders specifically related to the patient on drug-drug interactions, drug-lab interactions, and drugs … support rules to medication history documents in selected areas, such as inadequate lab monitoring, drugs … with abnormal labs, or drugs to avoid in the elderly. … Physicians strongly agreed that medication histories helped discover drugs which were previously unknown

14. Assessment of Pediatric Look-Alike, Sound-Alike (LASA) Substitution Errors - 2010 | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/assessment-pediatric-look-alike-sound-alike-lasa-substitution-errors/annual-summary/2010
    January 01, 2010 - Beginning with 17,000 medications, the team eliminated LASA pairs where one of the drugs in the pair … is either IV, topical, or where the pairs represent similar drugs (e.g. extended-release versions of … These are the drugs that will be included in the Delphi process to identify pairs that are of greatest … they have identified a Food and Drug Administration file that contains cross-references for brand name drugs … with their corresponding generic names, allowing the electronic linkage of drugs that are the same but

15. Electronic prescribing: Lowering Patients’ Prescription Drug Costs (pdf file)
    digital.ahrq.gov/sites/default/files/docs/page/THQITStoriesWeissman2010.pdf
    December 31, 2007 - Electronic Prescribing6 Lowering Patients’ Prescription Drug Costs The high cost of prescription drugs … prescription directly to a pharmacy.14 The system provides real­time information on the relative costs of drugs—or … Physicians select drugs from a color­coded list indicating the drug’s relative cost. … decision support, the e­prescribing system notifies participating physicians of typical doses for common drugs

16. A demonstration project: Assessing the significance and impact of utilizing a novel telemedicine application in the delivery of community based palliative care in a rural seriously ill population - Final Report (pdf file)
    digital.ahrq.gov/sites/default/files/docs/citation/r21hs026565-bull-final-report-2021.pdf
    January 01, 2021 - were involved in DDIs, and 51 drugs appeared in more than one interaction. … Table 3 shows the ten drugs that appeared most often in DDIs. … While 112 discrete drugs were involved in the 79 DDIs, 51 drugs (45.5%) appeared in more than one interaction … drug appeared in a DDI (%), N=235 interacting drugs. … Top 10 most common drugs involved in DDIs.

17. Durieux P et al. 2008 "Computerized advice on drug dosage to improve prescribing practice." | Digital Healthcare Research
    digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/durieux-p-et-al-2008
    January 01, 2008 - Abstract "Background: Maintaining therapeutic concentrations of drugs with a narrow therapeutic window … any change in the health of patients resulting from computerized advice (such as adverse reactions to drugs … were included (as compared to fifteen comparisons in the original review) including a wide range of drugs … change in the initial dose of drug but to have no effect on the maintenance dose and the total amount of drugs

18. R18Hs017203-Gurwitz-Final-Report-2011 (pdf file)
    digital.ahrq.gov/sites/default/files/docs/publication/r18hs017203-gurwitz-final-report-2011.pdf
    January 01, 2011 - Final guidelines included 35 drugs or drug classes and 61 laboratory tests. … ordered than for drugs without BBWs (86.4% vs 78.0%, p < 0.001). … Final guidelines included 38 drugs and drug classes and a total of 66 laboratory tests. … Final guidelines included 35 drugs/drug classes and 61 laboratory tests. … Rates of patient noncompletion of ordered tests for all drugs was generally <10%.

19. 08-1094 (pdf file)
    digital.ahrq.gov/sites/default/files/docs/page/08-1094.pdf
    January 02, 2025 - This includes information about eligibility, benefits (including drugs included in the applicable … and any requirements for prior authorization), the drug being prescribed or dispensed and other drugs … , drugs for which the beneficiary paid in cash, and drugs not covered under Medicare Part D, including … covered under Medicare Part D and not drugs provided during a hospital stay. … advance what other, less costly drugs within a given drug classification or generic drugs can be

20. Annotated Bibliography (pdf file)
    digital.ahrq.gov/sites/default/files/docs/Annotated%20Bibliography_Final.pdf
    June 27, 2008 - Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey … The Implications of Choice: Prescribing Generic or Preferred Pharmaceuticals Improves Medication Adherence